GlassScriptPhysician profile
Jodi M Winkel
NPI 1114988789
$4,890.13
in general payments reported to CMS, 2019-2025
39 companies · $761 in 2025
The $761 reported for 2025 was more than what 81% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $740 · 2020: $141 · 2021: $625 · 2022: $643 · 2023: $737 · 2024: $1,244 · 2025: $761.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,742.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,741.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,327.02 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $493.50 | 2019-2025 | Jardiance, Stiolto Respimat, Spiriva Respimat |
| Abbvie INC. | $329.12 | 2021-2025 | Vraylar, Ubrelvy |
| Lilly USA, LLC | $306.44 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $255.99 | 2019-2025 | Repatha, Otezla, Evenity |
| Bausch Health US, LLC | $226.16 | 2019-2025 | Wellbutrin, Aplenzin |
| Astrazeneca Pharmaceuticals LP | $201.07 | 2019-2025 | Airsupra, Farxiga |
| Abbott Laboratories | $192.74 | 2021-2024 | Freestyle Libre 3 |
| Pfizer INC. | $160.61 | 2019-2024 | |
| Exact Sciences Corporation | $131.07 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Gilead Sciences, INC. | $113.15 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $94.55 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $89.96 | 2019-2024 | Capvaxive, Gardasil, Gardasil 9 |
| Idorsia Pharmaceuticals US INC | $89.56 | 2023-2024 | Quviviq |
| Otsuka America Pharmaceutical, INC. | $86.35 | 2022-2025 | Rexulti |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jodi Winkel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.